NCT03589443View on ClinicalTrials.gov

Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 10, 2018

Primary Completion Date

February 4, 2019

Study Completion Date

February 4, 2019

Conditions
Barrett Esophagus
Interventions
DRUG

Multiplexed heptapeptides

Heptapeptides QRH and KSP

Trial Locations (1)

48109

University of Michigan Hospital, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT03589443 - Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus | Biotech Hunter | Biotech Hunter